ferumoxytol News

Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize
Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a n
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi

AMAG shares slump on new FDA letter

December 23, 2008 — 10:30am ET | By John Carroll

Shares of AMAG Pharmaceuticals plunged 20 percent after the company announced its second FDA response letter for its experimental anemia drug ferumoxytol. Regulators want more information on Read more...

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events

Most Popular ferumoxytol Story

AMAG shares slump on new FDA letter

ferumoxytol Press Releases

Latest Headlines

Paid Research Reports

THE FIERCEMARKETS NETWORK